Colman et al v. Theranos, Inc. et al

  1. April 19, 2017

    Indirect Share Purchasers Cleared To Sue Theranos

    Investors who purchased Theranos Inc. stocks through a third party can sue the company for securities fraud, and the investment firms that brokered the deals may be on the hook for fraud too, a California federal judge said on Tuesday.

  2. April 07, 2017

    Theranos Investors Can't Delay Class Action-Ending Deal

    A California federal judge refused Friday to push back a deadline for Theranos shareholders to agree to a deal that would resolve class allegations the company misled investors about the accuracy of its blood tests, finding that notices from the beleaguered startup disclosing terms of the deal aren't coercive or misleading.

  3. March 01, 2017

    Theranos Says Investors Can't Sue Over Blood Tests

    Beleaguered blood-testing startup Theranos and its executives urged a California federal judge Wednesday to toss a putative securities class action alleging they misled investors about the accuracy of Theranos' tests, saying the investors can't sue them because they didn't buy their securities directly from Theranos.

  4. November 28, 2016

    Theranos Stuck By Investor Suit Saying It Lied About Testing

    Investors led by Silicon Valley venture capital financier Robert Colman accused Theranos and its executives of violating securities and competition laws by hiding from the public that its blood testing technology promises had fallen through in a proposed class action filed Monday in California federal court.